Corwave Stock

www.corwave.comHealthcare / Medical DevicesFounded: 2012

Corwave, founded in 2012, is a medical device company and developer of implantable cardiac support devices aimed at aiding individuals dealing with heart failure. Their devices seek to employ an implantable heart pump that aims to leverage wave membrane pumping technology, using a fluctuating membrane to move fluid. This strives to allow patients to mitigate complications and decrease the discomfort and strain associated with invasive surgery. Corwave is headquartered in Clichy, Île-de-France.

Register for Details

For more details on financing and valuation for Corwave, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Corwave.

Register Today

Corwave investors also invested in these private companies

Ysios Capital
Exor
Vlerick Group
Medtronic
European Innovation Council Fund
Sofinnova Partners
Seventure Partners
Agoranov

Team

Management Team

Louis de Lillers
Chief Executive Officer
Zina Hamoumi
Chief Financial Officer
Carl Botterbusch
Chief Technology Officer

Board Members

Emmanuelle Coutanceau Ph.D
Novo Holdings
Philippe Boucheron
Bpifrance
Raúl Martín-Ruiz Ph.D
Ysios Capital

Other companies like Corwave in the Medical Devices sector

Sector
Last Round Est. Valuation
$3.45B
Sector
Last Round Est. Valuation
$263MM
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$943.68MM
Sector
Last Round Est. Valuation
$403.11MM
Sector
Last Round Est. Valuation
$1.35B
Sector
Last Round Est. Valuation
$893.88MM

News Highlights

CorWave Announces Second Closing of Its Series C Funding at €61M to Finance Its First Industrial Deployment
CorWave raised 61 million euros to fund its first industrial deployment and entry into clinical trials. SPI fund, managed by Bpifrance on behalf of the French Government as part of France 2030, and leading family controlled entrepreneurial groups were the main investors of this second closing.
Updated on: Sep 22, 2023